Evid Based Nurs 12:43 doi:10.1136/ebn.12.2.43
  • Treatment

Continuous glucose monitoring improved glycaemic control in pregnant women with diabetes and reduced infant macrosomia

H R Murphy

Dr H R Murphy, University of Cambridge, Cambridge, UK;


Does continuous glucose monitoring (CGM) improve glycaemic control in pregnant women with diabetes and reduce infant macrosomia?



randomised controlled trial. Current Controlled Trials ISRCTN84461581.





Follow-up period:

to delivery.


2 diabetes antenatal clinics in the UK.


71 pregnant women (mean age 31 y, mean gestational age 9 wks) who had type 1 diabetes (65% of women) or type 2 diabetes (35%) treated with insulin.


CGM plus standard antenatal care (n = 38) or standard care alone (n = 33). CGM was done every 4–6 weeks until 32 weeks of gestation. A subcutaneous sensor, attached to a portable monitor, was implanted by a nurse into the woman’s hip and worn for 5–7 days. The device recorded average tissue glucose concentrations every 5 minutes, but results were …

No Related Web Pages

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article